MYC and hepatocellular carcinoma: To investigate the growth inhibitory effect of miR-138 in vivo, we performed weekly intravenous miR-138 injections in LAP-tTA X tet-o-MYC transgenic mice which overexpresses human MYC CDS in the liver and is widely used to study MYC-driven HCC (Fig. 6A) [36].